-
Product Insights
New![]()
Net Present Value Model: Veru Inc’s VERU-100
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Veru Inc’s Enobosarm
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Veru Inc’s Sabizabulin Hydrochloride
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Company Profile
![]()
Veru Inc – Company Profile
Veru Inc (Veru) is a biopharmaceutical company that develop novel medicines for the management of breast cancer and prostate cancer. The company is headquartered in United States.
Add to Basket -
Product Insights
Verus Partners – Linfield Corporate Park Warehouse – Pennsylvania
Equip yourself with the essential tools needed to make informed and profitable decisions with our Verus Partners - Linfield Corporate Park Warehouse - Pennsylvania report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Verus Dev – 345 McLean Avenue Seniors Residential Building – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our Verus Dev - 345 McLean Avenue Seniors Residential Building - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Low Carbon/ Verus Energy/ Wheelabrator Tech – Kelvin Energy Recovery Facility – Sandwell
Equip yourself with the essential tools needed to make informed and profitable decisions with our Low Carbon/ Verus Energy/ Wheelabrator Tech - Kelvin Energy Recovery Facility - Sandwell report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sabizabulin Hydrochloride in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Sabizabulin Hydrochloride in Metastatic Castration-Resistant Prostate Cancer (mCRPC)Drug Details:Sabizabulin hydrochloride (VERU-111) is under development for the...
-
Product Insights
New![]()
Net Present Value Model: Tenaya Therapeutics Inc’s TN-301
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. Tenaya Therapeutics Inc's TN-301 Drug Details: TN-301 (TYA-11631) is under development for the treatment of heart failure (HF) with preserved ejection fraction (HFpEF)...
-
Thematic Analysis
New![]()
Aerospace, Defense and Security Industry Mergers and Acquisitions Deals by Top Themes in Q2 2023 – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q2 2023 in the Aerospace, Defense and Security Sector
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Finasteride + Tadalafil) in Benign Prostatic Hyperplasia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Finasteride + Tadalafil) in Benign Prostatic Hyperplasia Drug Details: Finasteride and tadalafil (Entadfi) is a...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MCARH-171 in Relapsed Multiple Myeloma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MCARH-171 in Relapsed Multiple Myeloma Drug Details: MCARH-171 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TST-003 in Metastatic Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TST-003 in Metastatic Colorectal CancerDrug Details:TST-003 is under development for the treatment of esophageal cancer, pancreatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – INCB-86550 in Melanoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.INCB-86550 in Melanoma Drug Details:INCB-86550 is under development for the treatment of advanced solid tumors including...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Enobosarm in Metastatic Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Enobosarm in Metastatic Breast Cancer Drug Details:Enobosarm (Ostarine, GTx-024, MK-2866) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TDI-01 in Pneumoconiosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TDI-01 in PneumoconiosisDrug Details:TDI-01 is under development for the treatment of non-alcoholic steatohepatitis (NASH), coronavirus disease...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CNMAU-8 in Primary Progressive Multiple Sclerosis (PPMS)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. CNMAU-8 in Primary Progressive Multiple Sclerosis (PPMS) Drug Details: CNMAU-8 is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Enobosarm in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Enobosarm in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Drug Details:Enobosarm...
-
Product Insights
West Bromwich Waste To Energy Project
West Bromwich Waste To Energy Project is a 49.9MW biopower power project located in England, United Kingdom. It is being developed by Verus Energy Ltd; Wheelabrator Technologies Inc. The project is currently in the financed stage. The project is expected to enter commercial operation in 2024. The project is owned by Low Carbon Ltd; Verus Energy Ltd; Wheelabrator Technologies Inc. West Bromwich Waste To Energy Project profile includes core details such as plant name, technology, capacity, status, plant proponents (owners,...
-
Product Insights
![]()
Net Present Value Model: VERU-100
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model VERU-100 Drug Details VERU-100 is under...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.